Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma
β Scribed by Kathryn C. Behling; Amy Tang; Boris Freydin; Inna Chervoneva; Sameep Kadakia; Gordon F. Schwartz; Hallgeir Rui; Agnieszka K. Witkiewicz
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 742 KB
- Volume
- 129
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Ductal carcinoma in situ (DCIS) in the male breast is a rare disease that to the authors' knowledge has been investigated to date only in small numbers. Compared with DCIS in the female breast, distinct clinical and morphologic differences have been suggested. ## METHODS. The fil
## Abstract Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. DCIS can recur or progress to invasive breast cancer, but the ability to predict the outcome of patients with DCIS remains limited, leading to inappropriate treatment choices. To